Vitrobio a family company

Founded in 1994, VITROBIO is a family-owned enterprise based in Issoire, Auvergne, France. This proud family business carries a strong commitment to advancing healthcare by providing innovative medical devices.

VITROBIO’s mission is to pioneer and develop effective medical devices to address a wide range of conditions that currently lack sufficient treatment options.  

Dr Ravi SHRIVASTAVA, Founder

  As Vitrobio's founder and a renowned scientist, Ravi Shrivastava developed the revolutionary multi-target polymer technology central to our products.

PhD in pharmacology | MBA  



As the current President, he is shaping the company's vision by tackling the challenges of the MDR regulation and advancing research to develop innovative treatments.

PhD in neurosciences | MBA 

International patents
Scientific publications
Scientific awards
Product references

International medical devices

As a reputable manufacturer of medical devices, VITROBIO collaborates with major pharmaceutical companies like UPSA, Sanofi, and Urgo to produce its products under a white label. These quality medical devices reach patients in over 20 countries worldwide, reflecting VITROBIO’s global presence and impact.

The company has set its sights on becoming a global leader in the manufacture and innovation of medical devices. VITROBIO is fully equipped to navigate the challenges posed by the new MDR 2017-745 regulation, which sets more stringent requirements for the marketing of medical devices.

Award-winning scientific research

Driven by core values emphasizing patient-focused research and natural technology applications, VITROBIO proudly manages the entire value chain of its products. This spans from fundamental research to the manufacturing of the finished product, regulatory documentation, and product registrations.

Over the years, VITROBIO has been recognized for its innovative work and groundbreaking contributions to the field of medical devices. The company has received several prestigious awards, including the Prince Louis de Polignac Prize from the French Academy of Sciences, the European PAEXA Award, the Auvergne Rhône-Alpes Booster Award, and the French National Assembly Award.


During the year 2023, VITROBIO is the recipient of support from the AUVERGNE-RHÔNE-ALPES REGION as it progresses through its EU 2017/745 medical CE marking process.


Innovative polymer-based technology

During 20 years of research, Vitrobio has developed a new technology based on natural polymers incorporated into a glycerol film. This innovation enables treatments to have a multi-target action by acting on several disease factors simultaneously.